<--- Back to Details
First PageDocument Content
Low molecular weight heparin / Factor X / Coagulation / Protamine sulfate / Partial thromboplastin time / Vitamin A / Biology / Heparins / Coagulation system / Medicine
Date: 2012-06-27 15:01:00
Low molecular weight heparin
Factor X
Coagulation
Protamine sulfate
Partial thromboplastin time
Vitamin A
Biology
Heparins
Coagulation system
Medicine

Figure 2: Mean ACT with Increasing Dose of M118

Add to Reading List

Source URL: www.momentapharma.com

Download Document from Source Website

File Size: 329,82 KB

Share Document on Facebook

Similar Documents

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Microsoft Wordfile00

Microsoft Wordfile00

DocID: 1r9dZ - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

RECOTHROM, Thrombin topical (Recombinant) Package Insert

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document